跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Novazinc - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Novazinc
Approved
STANDARD
Novazinc
Novagen Pharmaceutical Co., Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d43cf3606887ff04
Company
Novagen Pharmaceutical Co., Inc.
Type
Standard
Approval Details
Approval Id
d43cf3606887ff04
Drug Approval Philippines Name
Novazinc
Product Name
Novazinc
Registration Number
DR-XY47639
Brand Name
Novazinc
Generic Name
Ascorbic Acid + Zinc
Dosage Form
Capsule
Dosage Strength
500 mg (equivalent to 562.4 mg Sodium Ascorbate)/10 mg (30.25 mg Zinc Sulfate Monohydrate)
Manufacturer
Novagen Pharmaceutical Co., Inc.
Issuance Date
27 January 2022
Expiry Date
27 January 2027
Pharmacologic Category
Vitamin/Mineral
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d43cf3606887ff04
Type
Standard
Back to Philippines FDA Approvals